These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 28260159)

  • 1. Emerging biomarkers and screening for cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Lozupone M; Seripa D; Panza F; Yu Z
    Aging Clin Exp Res; 2017 Dec; 29(6):1075-1086. PubMed ID: 28260159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype.
    Panza F; Seripa D; Solfrizzi V; Tortelli R; Greco A; Pilotto A; Logroscino G
    J Alzheimers Dis; 2015; 47(4):793-813. PubMed ID: 26401761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention.
    Panza F; Lozupone M; Solfrizzi V; Sardone R; Dibello V; Di Lena L; D'Urso F; Stallone R; Petruzzi M; Giannelli G; Quaranta N; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G
    J Alzheimers Dis; 2018; 62(3):993-1012. PubMed ID: 29562543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition.
    Panza F; Solfrizzi V; Barulli MR; Santamato A; Seripa D; Pilotto A; Logroscino G
    Rejuvenation Res; 2015 Oct; 18(5):389-412. PubMed ID: 25808052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.
    Ruan Q; D'Onofrio G; Sancarlo D; Greco A; Yu Z
    Mol Med Rep; 2016 Oct; 14(4):3184-98. PubMed ID: 27511317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a Redefinition of Cognitive Frailty.
    Mantovani E; Zucchella C; Schena F; Romanelli MG; Venturelli M; Tamburin S
    J Alzheimers Dis; 2020; 76(3):831-843. PubMed ID: 32568197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders.
    Panza F; Solfrizzi V; Sardone R; Dibello V; Castellana F; Zupo R; Stallone R; Lampignano L; Bortone I; Mollica A; Berardino G; Ruan Q; Altamura M; Bellomo A; Daniele A; Lozupone M
    J Alzheimers Dis; 2023; 94(3):879-898. PubMed ID: 37355907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer's disease.
    Ohta Y; Nomura E; Hatanaka N; Osakada Y; Matsumoto N; Sasaki R; Tsunoda K; Takemoto M; Tadokoro K; Hishikawa N; Wakutani Y; Yamashita T; Sato K; Omote Y; Abe K
    J Clin Neurosci; 2019 Dec; 70():96-101. PubMed ID: 31444048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Current State of Cognitive Frailty: Measurement Properties.
    Sargent L; Brown R
    J Nutr Health Aging; 2017; 21(2):152-160. PubMed ID: 28112769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New clinical criteria for the Alzheimer's disease spectrum.
    Petersen RC
    Minn Med; 2012 Jan; 95(1):42-5. PubMed ID: 22355912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Case for Stage-Specific Frailty Interventions Spanning Community Aging to Cognitive Impairment.
    Chong MS; Tay L; Ismail NH; Tan CH; Yew S; Yeo A; Ye R; Leung B; Ding YY
    J Am Med Dir Assoc; 2015 Nov; 16(11):1003.e13-9. PubMed ID: 26543008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.